{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:59:26Z","timestamp":1791932366715,"version":"4.3.4"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T00:00:00Z","timestamp":1568073600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000774","name":"Defense Threat Reduction Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000774","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.antiviral.2019.104592","type":"journal-article","created":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T12:32:24Z","timestamp":1567081944000},"page":"104592","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Cholesterol-conjugated stapled peptides inhibit Ebola and Marburg viruses in vitro and in vivo"],"prefix":"10.1016","volume":"171","author":[{"given":"Antonello","family":"Pessi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra L.","family":"Bixler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Soloveva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheli","family":"Radoshitzky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cary","family":"Retterer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Kenny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rouzbeh","family":"Zamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn","family":"Gomba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dima","family":"Gharabeih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Wells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly S.","family":"Wetzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis K.","family":"Warren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ginger","family":"Donnelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean A.","family":"Van Tongeren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse","family":"Steffens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen J.","family":"Duplantier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher D.","family":"Kane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Vicat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Couturier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kent E.","family":"Kester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Shiver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sina","family":"Bavari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2019.104592_bib1","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00346-16","article-title":"Chasing ebola through the endosomal labyrinth","volume":"7","author":"Aman","year":"2016","journal-title":"mBio"},{"key":"10.1016\/j.antiviral.2019.104592_bib2","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1093\/jac\/dkt529","article-title":"Improvement of HIV fusion inhibitor C34 efficacy by membrane anchoring and enhanced exposure","volume":"69","author":"Augusto","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.antiviral.2019.104592_bib3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/pro.5560070103","article-title":"Helix capping","volume":"7","author":"Aurora","year":"1998","journal-title":"Protein Sci."},{"key":"10.1016\/j.antiviral.2019.104592_bib4","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1172\/JCI71856","article-title":"Mucosal delivery of a double-stapled RSV peptide prevents nasopulmonary infection","volume":"124","author":"Bird","year":"2014","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.antiviral.2019.104592_bib5","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/nsmb.2922","article-title":"Stapled HIV-1 peptides recapitulate antigenic structures and engage broadly neutralizing antibodies","volume":"21","author":"Bird","year":"2014","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.antiviral.2019.104592_bib6","doi-asserted-by":"crossref","first-page":"14093","DOI":"10.1073\/pnas.1002713107","article-title":"Hydrocarbon double-stapling remedies the proteolytic instability of a lengthy peptide therapeutic","volume":"107","author":"Bird","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2019.104592_bib7","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.antiviral.2017.12.021","article-title":"Efficacy of favipiravir (T-705) in nonhuman primates infected with Ebola virus or Marburg virus","volume":"151","author":"Bixler","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.104592_bib8","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1126\/science.aad5788","article-title":"Isolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreak","volume":"351","author":"Bornholdt","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2019.104592_bib9","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1086\/515386","article-title":"A mouse model for evaluation of prophylaxis and therapy of Ebola hemorrhagic fever","volume":"178","author":"Bray","year":"1998","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2019.104592_bib10","doi-asserted-by":"crossref","first-page":"5389","DOI":"10.1021\/jm030210x","article-title":"An alpha helix conformationally restricted peptide is recognized by cervical carcinoma patients' sera","volume":"46","author":"Calvo","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2019.104592_bib11","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nature10348","article-title":"Ebola virus entry requires the cholesterol transporter Niemann-Pick C1","volume":"477","author":"Carette","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2019.104592_bib12","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1126\/science.1110656","article-title":"Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection","volume":"308","author":"Chandran","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2019.104592_bib13","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/nature10380","article-title":"Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection","volume":"477","author":"Cote","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2019.104592_bib14","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nrd.2017.251","article-title":"Post-exposure treatments for Ebola and Marburg virus infections","volume":"17","author":"Cross","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.antiviral.2019.104592_bib15","doi-asserted-by":"crossref","first-page":"6965","DOI":"10.1002\/anie.201310245","article-title":"Comparative alpha-helicity of cyclic pentapeptides in water","volume":"53","author":"de Araujo","year":"2014","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.antiviral.2019.104592_bib16","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1146\/annurev.biochem.70.1.777","article-title":"Mechanisms of viral membrane fusion and its inhibition","volume":"70","author":"Eckert","year":"2001","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.antiviral.2019.104592_bib17","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/bip.22877","article-title":"Review stapling peptides using cysteine crosslinking","volume":"106","author":"Fairlie","year":"2016","journal-title":"Biopolymers"},{"key":"10.1016\/j.antiviral.2019.104592_bib18","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(10)60667-8","article-title":"Ebola haemorrhagic fever","volume":"377","author":"Feldmann","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2019.104592_bib19","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.cell.2015.12.022","article-title":"Cross-reactive and potent neutralizing antibody responses in human survivors of natural ebolavirus infection","volume":"164","author":"Flyak","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2019.104592_bib20","doi-asserted-by":"crossref","first-page":"19193","DOI":"10.1038\/srep19193","article-title":"Bispecific antibody affords complete post-exposure protection of mice from both ebola (Zaire) and Sudan viruses","volume":"6","author":"Frei","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2019.104592_bib21","doi-asserted-by":"crossref","first-page":"20514","DOI":"10.1038\/srep20514","article-title":"Discovery of an antibody for pan-ebolavirus therapy","volume":"6","author":"Furuyama","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2019.104592_bib22","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02241-16","article-title":"A short double-stapled peptide inhibits respiratory syncytial virus entry and spreading","volume":"61","author":"Gaillard","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2019.104592_bib23","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0092-8674(00)81248-9","article-title":"Similar structural models of the transmembrane proteins of Ebola and avian sarcoma viruses","volume":"85","author":"Gallaher","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.antiviral.2019.104592_bib24","doi-asserted-by":"crossref","first-page":"5892","DOI":"10.1128\/AAC.01105-15","article-title":"Addressing therapeutic options for ebola virus infection in current and future outbreaks","volume":"59","author":"Haque","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2019.104592_bib25","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1002\/pro.688","article-title":"Designed protein mimics of the Ebola virus glycoprotein GP2 alpha-helical bundle: stability and pH effects","volume":"20","author":"Harrison","year":"2011","journal-title":"Protein Sci."},{"key":"10.1016\/j.antiviral.2019.104592_bib26","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1021\/bi3000353","article-title":"Marburg virus glycoprotein GP2: pH-dependent stability of the ectodomain alpha-helical bundle","volume":"51","author":"Harrison","year":"2012","journal-title":"Biochemistry"},{"key":"10.1016\/j.antiviral.2019.104592_bib27","doi-asserted-by":"crossref","first-page":"11686","DOI":"10.1073\/pnas.1002498107","article-title":"Downsizing human, bacterial, and viral proteins to short water-stable alpha helices that maintain biological potency","volume":"107","author":"Harrison","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2019.104592_bib28","doi-asserted-by":"crossref","first-page":"11126","DOI":"10.1074\/jbc.M800200200","article-title":"Design and evaluation of sifuvirtide, a novel HIV-1 fusion inhibitor","volume":"283","author":"He","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2019.104592_bib29","doi-asserted-by":"crossref","first-page":"5356","DOI":"10.1016\/j.bmcl.2013.07.056","article-title":"C-peptide inhibitors of Ebola virus glycoprotein-mediated cell entry: effects of conjugation to cholesterol and side chain-side chain crosslinking","volume":"23","author":"Higgins","year":"2013","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.antiviral.2019.104592_bib30","doi-asserted-by":"crossref","first-page":"7445","DOI":"10.1021\/acs.jmedchem.6b00265","article-title":"Development of a single-chain peptide agonist of the relaxin-3 receptor using hydrocarbon stapling","volume":"59","author":"Hojo","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2019.104592_bib31","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nature19790","article-title":"The evolution of Ebola virus: insights from the 2013-2016 epidemic","volume":"538","author":"Holmes","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2019.104592_bib32","doi-asserted-by":"crossref","first-page":"5801","DOI":"10.1073\/pnas.0901007106","article-title":"Addition of a cholesterol group to an HIV-1 peptide fusion inhibitor dramatically increases its antiviral potency","volume":"106","author":"Ingallinella","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2019.104592_bib33","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/nprot.2011.324","article-title":"Synthesis of all-hydrocarbon stapled alpha-helical peptides by ring-closing olefin metathesis","volume":"6","author":"Kim","year":"2011","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.antiviral.2019.104592_bib34","doi-asserted-by":"crossref","first-page":"7665","DOI":"10.1021\/bi300976m","article-title":"Crystal structure of the Marburg virus GP2 core domain in its postfusion conformation","volume":"51","author":"Koellhoffer","year":"2012","journal-title":"Biochemistry"},{"key":"10.1016\/j.antiviral.2019.104592_bib35","doi-asserted-by":"crossref","first-page":"4760","DOI":"10.3390\/v6114760","article-title":"Nomenclature- and database-compatible names for the two Ebola virus variants that emerged in Guinea and the Democratic Republic of the Congo in 2014","volume":"6","author":"Kuhn","year":"2014","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2019.104592_bib36","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.3390\/v6093663","article-title":"Filovirus RefSeq entries: evaluation and selection of filovirus type variants, type sequences, and names","volume":"6","author":"Kuhn","year":"2014","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2019.104592_bib37","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nrd1091","article-title":"Enfuvirtide","volume":"2","author":"LaBonte","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.antiviral.2019.104592_bib38","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1073\/pnas.93.5.2186","article-title":"Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion","volume":"93","author":"Lambert","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2019.104592_bib39","doi-asserted-by":"crossref","first-page":"11273","DOI":"10.1073\/pnas.1934759100","article-title":"Helix-stabilized cyclic peptides as selective inhibitors of steroid receptor-coactivator interactions","volume":"100","author":"Leduc","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2019.104592_bib40","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nature07082","article-title":"Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor","volume":"454","author":"Lee","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2019.104592_bib41","doi-asserted-by":"crossref","first-page":"42141","DOI":"10.1074\/jbc.M111.254243","article-title":"Capturing a fusion intermediate of influenza hemagglutinin with a cholesterol-conjugated peptide, a new antiviral strategy for influenza virus","volume":"286","author":"Lee","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2019.104592_bib42","doi-asserted-by":"crossref","first-page":"9223","DOI":"10.1128\/JVI.01153-13","article-title":"A cholesterol tag at the N terminus of the relatively broad-spectrum fusion inhibitory peptide targets an earlier stage of fusion glycoprotein activation and increases the peptide's antiviral potency in vivo","volume":"87","author":"Li","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104592_bib43","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1073\/pnas.96.6.2662","article-title":"Core structure of the envelope glycoprotein GP2 from Ebola virus at 1.9-A resolution","volume":"96","author":"Malashkevich","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2019.104592_bib44","doi-asserted-by":"crossref","first-page":"43610","DOI":"10.1038\/srep43610","article-title":"Broad spectrum antiviral activity for paramyxoviruses is modulated by biophysical properties of fusion inhibitory peptides","volume":"7","author":"Mathieu","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2019.104592_bib45","doi-asserted-by":"crossref","first-page":"15854","DOI":"10.1074\/jbc.M110.207084","article-title":"Inhibition of Ebola virus entry by a C-peptide targeted to endosomes","volume":"286","author":"Miller","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2019.104592_bib46","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1126\/science.aad6117","article-title":"Structural and molecular basis for Ebola virus neutralization by protective human antibodies","volume":"351","author":"Misasi","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2019.104592_bib47","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.virol.2011.08.009","article-title":"The Ebola virus glycoprotein mediates entry via a non-classical dynamin-dependent macropinocytic pathway","volume":"419","author":"Mulherkar","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2019.104592_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001121","article-title":"Ebolavirus is internalized into host cells via macropinocytosis in a viral glycoprotein-dependent manner","volume":"6","author":"Nanbo","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2019.104592_bib49","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1021\/id500025n","article-title":"Chemical and structural aspects of ebola virus entry inhibitors","volume":"1","author":"Nyakatura","year":"2015","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.antiviral.2019.104592_bib50","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/psc.2706","article-title":"Cholesterol-conjugated peptide antivirals: a path to a rapid response to emerging viral diseases","volume":"21","author":"Pessi","year":"2015","journal-title":"J. Pept. Sci."},{"key":"10.1016\/j.antiviral.2019.104592_bib51","doi-asserted-by":"crossref","first-page":"9837","DOI":"10.1128\/JVI.00736-06","article-title":"Inhibition of hendra virus fusion","volume":"80","author":"Porotto","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104592_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001168","article-title":"Inhibition of Nipah virus infection in vivo: targeting an early stage of paramyxovirus fusion activation during viral entry","volume":"6","author":"Porotto","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2019.104592_bib53","doi-asserted-by":"crossref","first-page":"6760","DOI":"10.1128\/JVI.00135-10","article-title":"Viral entry inhibitors targeted to the membrane site of action","volume":"84","author":"Porotto","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104592_bib54","doi-asserted-by":"crossref","first-page":"329ra333","DOI":"10.1126\/scitranslmed.aad9875","article-title":"Two-mAb cocktail protects macaques against the Makona variant of Ebola virus","volume":"8","author":"Qiu","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.antiviral.2019.104592_bib55","doi-asserted-by":"crossref","first-page":"8502","DOI":"10.1128\/JVI.02600-10","article-title":"Ebolavirus delta-peptide immunoadhesins inhibit marburgvirus and ebolavirus cell entry","volume":"85","author":"Radoshitzky","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104592_bib56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001110","article-title":"Cellular entry of ebola virus involves uptake by a macropinocytosis-like mechanism and subsequent trafficking through early and late endosomes","volume":"6","author":"Saeed","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2019.104592_bib57","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev.bb.21.060192.000523","article-title":"The mechanism of alpha-helix formation by peptides","volume":"21","author":"Scholtz","year":"1992","journal-title":"Annu. Rev. Biophys. Biomol. Struct."},{"key":"10.1016\/j.antiviral.2019.104592_bib58","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1021\/ja0456003","article-title":"Single turn peptide alpha helices with exceptional stability in water","volume":"127","author":"Shepherd","year":"2005","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.antiviral.2019.104592_bib59","doi-asserted-by":"crossref","first-page":"13284","DOI":"10.1021\/ja064058a","article-title":"Modular alpha-helical mimetics with antiviral activity against respiratory syncitial virus","volume":"128","author":"Shepherd","year":"2006","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.antiviral.2019.104592_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004802","article-title":"Next steps for ebola vaccination: deployment in non-epidemic, high-risk settings","volume":"10","author":"Skrip","year":"2016","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.antiviral.2019.104592_bib61","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/j.drudis.2016.06.012","article-title":"Stapled peptide design: principles and roles of computation","volume":"21","author":"Tan","year":"2016","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.antiviral.2019.104592_bib62","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/bip.10203","article-title":"The synthesis and study of side-chain lactam-bridged peptides","volume":"66","author":"Taylor","year":"2002","journal-title":"Biopolymers"},{"key":"10.1016\/j.antiviral.2019.104592_bib63","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nature17180","article-title":"Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys","volume":"531","author":"Warren","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2019.104592_bib64","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nature13027","article-title":"Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430","volume":"508","author":"Warren","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2019.104592_bib65","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1126\/science.aag3267","article-title":"A \u201cTrojan horse\u201d bispecific-antibody strategy for broad protection against ebolaviruses","volume":"354","author":"Wec","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2019.104592_bib66","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S1097-2765(00)80159-8","article-title":"Crystal structure of the Ebola virus membrane fusion subunit, GP2, from the envelope glycoprotein ectodomain","volume":"2","author":"Weissenhorn","year":"1998","journal-title":"Mol. Cell"},{"key":"10.1016\/j.antiviral.2019.104592_bib67","doi-asserted-by":"crossref","first-page":"13785","DOI":"10.1128\/JVI.02436-13","article-title":"Fatal measles virus infection prevented by brain-penetrant fusion inhibitors","volume":"87","author":"Welsch","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104592_bib68","doi-asserted-by":"crossref","first-page":"6788","DOI":"10.1074\/jbc.M111.317883","article-title":"Broad antiviral activity and crystal structure of HIV-1 fusion inhibitor sifuvirtide","volume":"287","author":"Yao","year":"2012","journal-title":"J. Biol. Chem."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219302992?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219302992?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:30:03Z","timestamp":1759062603000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354219302992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":68,"alternative-id":["S0166354219302992"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.104592","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cholesterol-conjugated stapled peptides inhibit Ebola and Marburg viruses in vitro and in vivo","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.104592","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104592"}}